Cardiac amyloidosis: shifting our impressions to hopeful (Q36574990)

15 August 2017

1 reference

title

Cardiac amyloidosis: shifting our impressions to hopeful (English)

1 reference

15 August 2017

Douglas B Sawyer

1

1 reference

PubMed ID

16928339

15 August 2017

Martha Skinner

series ordinal

2

1 reference

15 August 2017

1 June 2006

1 reference

Current heart failure reports

15 August 2017

1 reference

15 August 2017

3

1 reference

15 August 2017

2

1 reference

15 August 2017

64-71

1 reference

https://scigraph.springernature.com/pub.10.1007/s11897-006-0004-z

15 August 2017

0 references

cites work

Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11897-006-0004-Z

Resolution of heart failure in patients with AL amyloidosis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11897-006-0004-Z

Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation

21 January 2018

1 reference

12 December 2020

Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts

1 reference

12 December 2020

Holter monitoring in AL amyloidosis: prognostic implications

1 reference

12 December 2020

Heart transplantation in patients with amyloidosis: single-center experience

1 reference

12 December 2020

Primary systemic amyloidosis: clinical and laboratory features in 474 cases.

1 reference

12 December 2020

Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy

1 reference

12 December 2020

Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

1 reference

12 December 2020

Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis.

1 reference

12 December 2020

Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management

1 reference

12 December 2020

Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation.

1 reference

12 December 2020

High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial

1 reference

12 December 2020

Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis

1 reference

12 December 2020

Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins

1 reference

12 December 2020

Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis.

1 reference

12 December 2020

Rational design of potent human transthyretin amyloid disease inhibitors

1 reference

12 December 2020

Diagnosis and management of the cardiac amyloidoses

1 reference

12 December 2020

Combined heart and liver transplantation in four adults with familial amyloidosis: experience of a single center

1 reference

12 December 2020

Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type.

1 reference

12 December 2020

Guidelines on the diagnosis and management of AL amyloidosis

1 reference

12 December 2020

Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents

1 reference

12 December 2020

Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin

1 reference

12 December 2020

Comparison of usefulness between exercise capacity and echocardiographic indexes of left ventricular function in cardiac amyloidosis

1 reference

12 December 2020

Noninvasive diagnosis of biopsy-proven cardiac amyloidosis

1 reference

12 December 2020

Clinical significance of histopathologic patterns of cardiac amyloidosis

1 reference

12 December 2020

The diagnosis and typing of cardiac amyloidosis

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement.

1 reference

12 December 2020

Digoxin sensitivity in amyloid cardiomyopathy

1 reference

12 December 2020

Long-term successful outcome of sequential cardiac and allogeneic bone marrow transplantations in severe AL amyloidosis

1 reference

12 December 2020

Out-of-hospital cardiac arrest in patients with cardiac amyloidosis: presenting rhythms, management and outcomes in four patients.

1 reference

12 December 2020

High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study

1 reference

12 December 2020

Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989

1 reference

12 December 2020

Symptomatic ischemic heart disease resulting from obstructive intramural coronary amyloidosis

1 reference

12 December 2020

Successful intermediate-term outcome for patients with cardiac amyloidosis undergoing heart transplantation: results of a multicenter survey

1 reference

12 December 2020

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

1 reference

12 December 2020

Implantation of a cardioverter-defibrillator in a patient with cardiac amyloidosis

1 reference

12 December 2020

Is elevated plasma B-natriuretic peptide in amyloidosis simply a function of the presence of heart failure?

1 reference

12 December 2020

Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress.

1 reference

12 December 2020

Molecular mechanisms of amyloidosis

1 reference

12 December 2020

10.1007/S11897-006-0004-Z

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

16928339